The Future of Ketamine and Mood Disorders In 2019, the FDA and European Fee authorized the usage of an esketamine nasal spready beneath the brand identify Spravato to deal with despair. Even so, as of 2021, ketamine hasn't been authorised through the FDA to deal with despair or other mental wellbeing disorders, and as a consequence, the medication